News related to Optimark (Gadoversetamide) and/or conditions it is approved for
FDA approves new diagnostic imaging agent to detect recurrent prostate cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2016.05.31]
The U.S. Food and Drug Administration has approved Axumin, a radioactive diagnostic agent for injection.
Flexible future of point-of-care disease diagnostic
Source: Bird Flu / Avian Flu News From Medical News Today [2015.07.29]
The world-wide deployment of biomedical devices for health monitoring, point-of-care diagnostics and environmental sensing is hampered by their high cost that is not readily affordable for e.g.
Artificial enzymes used in wide range of household products are "potent allergens"
Source: Allergy News From Medical News Today [2016.09.22]
But no commercially available diagnostic tests to monitor this potential new health risk.
Molecular Testing of Cancers: 'Let's Try to Get It Right'
Source: Medscape Internal Medicine Headlines [2016.09.21]
Use of molecular diagnostics in cancer can be tricky, but Dr Lundberg says the pathologist can ask important questions to help guide the process.
Medscape Internal Medicine
Prenatal Ultrasound Tied to Autism Severity in At-Risk Kids
Source: Medscape Psychiatry & Mental Health Headlines [2016.09.21]
First-trimester diagnostic ultrasound has been linked to greater autism symptom severity, particularly in genetically vulnerable boys.
Medscape Medical News
Adverse outcomes not improved in novel screen-and-treat program for malaria in pregnancy
Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today [2016.09.14]
A novel strategy to screen pregnant women for malaria with rapid diagnostic tests and treat the test-positive women with effective antimalarials does not lower the risk of adverse pregnancy...
Simple, sensitive, and cost-effective assays for analyzing fragile X
Source: Autism News From Medical News Today [2016.08.12]
Tests useful for preclinical and clinical research on a genetic mutation related to autism and intellectual disability may become more available, reports The Journal of Molecular Diagnostics.
FDA approves first blood test to detect gene mutation associated with non-small cell lung cancer
Source: Lung Cancer News From Medical News Today [2016.06.02]
The U.S. Food and Drug Administration has approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib).
ADHD in young adulthood examined in JAMA Psychiatry studies
Source: ADHD / ADD News From Medical News Today [2016.05.18]
Many Young Adults with ADHD Did Not Have Childhood Diagnosis Among a group of young adults with ADHD at age 18, many of them did not meet diagnostic criteria for ADHD at any assessment in...
Breath test may help diagnose irritable bowel syndrome
Source: Irritable Bowel Syndrome News From Medical News Today [2016.05.11]
There is currently no specific diagnostic test for irritable bowel syndrome (IBS), but now researchers have identified a combination of 16 different substances in the breath that, when measured...
Nearly half of heart bypass patients skip medications that keep blood flowing
Source: Statins News From Medical News Today [2016.05.03]
Researchers at Thomas Jefferson University discovered that nearly half of coronary artery bypass patients are not taking statins and aspirin together when they are referred for diagnostic cardiac...
AMP genomic sequencing procedure microcosting & health economic cost-impact analyses
Source: Hearing / Deafness News From Medical News Today [2016.04.14]
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, has announced the results from a 2015 analysis of the costs...
New assay offers improved detection of deadly prion diseases
Source: CJD / vCJD / Mad Cow Disease News From Medical News Today [2016.04.11]
Timed amyloid seeding assay achieves or surpasses sensitivity of currently available tests for transmissible spongiform encephalopathies, according to a report in The Journal of Molecular Diagnostics.
Study shows test aids physicians in Tamoxifen drug monitoring, including non-compliance due to side effects
Source: Compliance News From Medical News Today [2015.12.15]
A study from Quest Diagnostics medical experts shows how a lab-developed test could help assess levels of several tamoxifen drug metabolites in a blood specimen.